Scolaris Content Display Scolaris Content Display

Systemic and topical antibiotics for chronic rhinosinusitis

Esta versión no es la más reciente

Referencias

Additional references

Bucher 2004

Bucher HC, Tschudi P, Young J, Périat P, Welge‐Lüussen A, Züst H, et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine 2004;163(15):1793‐8.

Cho 2012

Cho SH, Hong SJ, Han B, Lee SH, Suh L, Norton J, et al. Age‐related differences in the pathogenesis of chronic rhinosinusitis. Journal of Allergy and Clinical Immunology 2012;129(3):858‐60.e2.

Chong 2015a

Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Different types of intranasal steroids for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.

Chong 2015b

Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.

Chong 2015c

Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Short‐course oral steroids alone for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.

Chong 2015d

Chong LY, Head K, Hopkins C, Philpott C, Schilder AGM. Saline irrigation for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.

Chong 2015e

Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.

DeMarcantonio 2011

DeMarcantonio MA, Han JK. Nasal polyps: pathogenesis and treatment implications. Otolaryngologic Clinics of North America 2011;44(3):685‐95, ix.

Ebbens 2010

Ebbens FA, Toppila‐Salmi SK, Renkonen JA, Renkonen RL, Mullol J, van Drunen CM, et al. Endothelial L‐selectin ligand expression in nasal polyps. Allergy 2010;65(1):95‐102.

Ebbens 2011

Ebbens FA, Toppila‐Salmi S, de Groot EJ, Renkonen J, Renkonen R, van Drunen CM, et al. Predictors of post‐operative response to treatment: a double blind placebo controlled study in chronic rhinosinusitis patients. Rhinology 2011;49(4):413‐9.

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629‐34. [PUBMED: 9310563]

Fokkens 2007

Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology 2007;45(Suppl 20):1‐139.

Gliklich 1995

Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngology ‐ Head and Neck Surgery 1995;113(1):104‐9.

Gulliford 2014

Gulliford MC, Dregan A, Moore MV, Ashworth M, Staa Tv, McCann G, et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014;4(10):e006245.

Handbook 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hastan 2011

Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe ‐ an underestimated disease. A GA2LEN study. Allergy 2011;66(9):1216‐23.

Hatipoglu 2005

Hatipoglu U, Rubinstein I. Treatment of chronic rhinosinusitis with low‐dose, long‐term macrolide antibiotics: an evolving paradigm. Current Allergy and Asthma Reports 2005;5:491‐4.

Inamura 2000

Inamura K, Ohta N, Fukase S, Kasajima N, Aoyagi M. The effect of erythromycin on human peripheral neutrophil apoptosis. Rhinology 2000;38:124‐9.

Kern 2008

Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi‐Peters A, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. American Journal of Rhinology 2008;22(6):549‐59.

Keswani 2012

Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK, et al. Differential expression of interleukin‐32 in chronic rhinosinusitis with and without nasal polyps. Allergy 2012;67(1):25‐32.

Larsen 2004

Larsen P, Tos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope 2004;114(4):710‐9.

MacLaughlin 2000

MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta‐lactam allergies: selection and costs of antibiotics for patients with a reported beta‐lactam allergy. Archives of Family Medicine 2000;9(8):722‐6.

Miyanohara 2000

Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000;110:126‐31.

Piromchai 2011

Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD008233.pub2]

Ragab 2004

Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114(5):923‐30.

Ragab 2010

Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology 2010;48(3):305‐11.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Tan 2011

Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology 2011;128(6):1198‐206.e1.

Tomassen 2011

Tomassen P, Van Zele T, Zhang N, Perez‐ Novo C, Van Bruaene N, Gevaert P, et al. Pathophysiology of chronic rhinosinusitis. Proceedings of the American Thoracic Society 2011;8(1):115‐20.

van Drunen 2009

van Drunen CM, Reinartz SM, Wigman J, Fokkens W. Inflammation in chronic rhinosinusitis and nasal polyposis. Immunology and Allergy Clinics of North America 2009;29(4):621‐9.

Wallwork 2006

Wallwork B, Coman W, Mackay SA, Greiff L, Cervin A. A double‐blind, randomized, placebo‐controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116;2:189‐93.

Wozniak 2004

Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004;125:62S‐9S.

Zhang 2008

Zhang N, Van Zele T, Perez‐Novo C, Van Bruaene N, Holtappels G, DeRuyck N, et al. Different types of T‐effector cells orchestrate mucosal inflammation in chronic sinus disease. Journal of Allergy and Clinical Immunology 2008;122(5):961‐8.

Zhang 2009

Zhang XH, Lu X, Long XB, You XJ, Gao QX, Cui YH, et al. Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid‐induced leucine zipper. Clinical and Experimental Allergy 2009;39(5):647‐54.